These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2341749)

  • 1. Production of antitumor mononuclear blood cells in tumor-bearing mice by interferon-alpha A/D therapy.
    Honjo K; Suhara Y; Taniyama T; Kataoka T
    J Interferon Res; 1990 Apr; 10(2):191-202. PubMed ID: 2341749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative contribution of antiproliferative and host immunity-associated activity of mouse interferon in murine tumor therapy.
    Kataoka T; Oh-hashi F; Sakurai Y; Usuki K; Ida N
    Cancer Res; 1984 Dec; 44(12 Pt 1):5661-5. PubMed ID: 6498826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment regimen and host T-cell-dependent therapeutic effect of interferon in mouse solid tumors.
    Kataoka T; Matsuura N; Oh-hashi F; Suhara Y
    Cancer Res; 1985 Aug; 45(8):3548-53. PubMed ID: 2410097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of T cells in lymphoid organs induced by interferon in tumor-bearing mice.
    Kataoka T; Honjo K; Oh-Hashi F; Murayama NM; Suhara Y
    J Interferon Res; 1990 Apr; 10(2):161-71. PubMed ID: 2341748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activation and regulation of macrophages induced by inoculation of cryodestroyed tumor cells].
    Tsujino M
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):180-205. PubMed ID: 2135404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
    Mizushima Y; Morikage T; Hirata H; Sato M; Sakamoto K; Yano S
    J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of host T and non-T cells recovered from tumor nodules after interferon therapy.
    Honjo K; Suhara Y; Kataoka T
    Jpn J Cancer Res; 1990 Apr; 81(4):410-5. PubMed ID: 2114393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of co-administration of granulocyte colony-stimulating factor on interferon therapy.
    Segawa K; Suhara Y; Ueno Y; Kataoka T
    Jpn J Cancer Res; 1991 Mar; 82(3):346-50. PubMed ID: 1708757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of the antitumor activity of 5,5'-bis(2'-tetrahydropyranyl) secalonic acid D against Meth-A.
    Shimizu M; Nakamura M; Kataoka T; Iwaguchi T
    Cancer Chemother Pharmacol; 1983; 11(3):144-6. PubMed ID: 6416694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of recombinant human interferon alpha A/D on Meth-A sarcoma in mice.
    Yoshie O; Aso H; Nanjo M; Tamura K; Ebina T; Ishida N
    Jpn J Cancer Res; 1986 Apr; 77(4):413-8. PubMed ID: 3084432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant human interferon-alpha A/D on in vivo murine tumor cell growth.
    Uno K; Shimizu S; Inaba K; Kitaura M; Nakahira K; Kato T; Yamaguchi Y; Muramatsu S
    Cancer Res; 1988 May; 48(9):2366-71. PubMed ID: 3356004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An increase of B cells in the tumor-bearing state has the potential to induce anti-tumor immunity.
    Ito O; Harada M; Takenoyama M; Sumichika H; Matsuzaki G; Nomoto K
    Immunobiology; 1996 Jan; 195(1):1-15. PubMed ID: 8852597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The "double grafted tumor system", proposed to find effector cells in the analyses of antitumor effect of BRMs.
    Kohya H; Ebina T; Yamaguchi T; Ishida N
    Biotherapy; 1989; 1(3):139-51. PubMed ID: 2534966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of interferon-gamma by in vivo tumor-sensitized T cells: association with active antitumor immunity.
    Bursuker I; Pearce MT
    J Interferon Res; 1990 Feb; 10(1):1-11. PubMed ID: 2109780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct antiproliferative effects of recombinant human interferon-alpha B/D hybrids on human tumor cell lines.
    Fidler IJ; Heicappell R; Saiki I; Grutter MG; Horisberger MA; Nuesch J
    Cancer Res; 1987 Apr; 47(8):2020-7. PubMed ID: 3828990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells.
    Zou JP; Yamamoto N; Fujii T; Takenaka H; Kobayashi M; Herrmann SH; Wolf SF; Fujiwara H; Hamaoka T
    Int Immunol; 1995 Jul; 7(7):1135-45. PubMed ID: 8527411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitumor effect of human recombinant interferon-alpha A/D in mice(I): Comparison between systemic and lesional treatment of meth-A sarcoma in BALB/c mice].
    Nanjo M; Yoshie O; Aso H; Ebina T; Ishida N
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):505-9. PubMed ID: 4004283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
    Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
    Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eriobotrya japonica hydrophilic extract modulates cytokines in normal tissues, in the tumor of Meth-A-fibrosarcoma bearing mice, and enhances their survival time.
    Alshaker HA; Qinna NA; Qadan F; Bustami M; Matalka KZ
    BMC Complement Altern Med; 2011 Feb; 11():9. PubMed ID: 21294856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.